NSF Program To Encourage University Science Entrepreneurs Set For Slow Start

NSF told Congress about a great new plan for technology transfer but doesn't intend to spend much money on it WASHINGTON -- The National Science Foundation wants more university scientists to get into the technology transfer act. But a new program to do just that seeks only one tenth its originally planned funding. It also offers little assurance that the program will be around long enough to generate any commercial products. Last year NSF presented Congress with its plans for an $85 million

Written byElizabeth Pennisi
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share


NSF told Congress about a great new plan for technology transfer but doesn't intend to spend much money on it
WASHINGTON -- The National Science Foundation wants more university scientists to get into the technology transfer act. But a new program to do just that seeks only one tenth its originally planned funding. It also offers little assurance that the program will be around long enough to generate any commercial products.

Last year NSF presented Congress with its plans for an $85 million College and University Innovation Research (CUIR) program. The NSF report outlined a six-year pilot project that would be modeled after the popular, government-wide Small Business Innovation Research (SBIR) program. The report was presented in response to calls from Sen. James Exon (D-Neb.) that NSF do more to encourage university researchers to transfer technology from their institutions to industry.

But instead of asking for $5 million to launch ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies